
Hagop Youssoufian/c4therapeutics.com
Aug 28, 2025, 15:19
Hagop Youssoufian Highlights TREOS BIO’s Collaboration in Colorectal Cancer Treatment
Hagop Youssoufian, Founder and Principal at Youssoufian Consulting, LLC, shared a post on LinkedIn:
“Excited by TREOS BIO’s collaboration in colorectal cancer with Charité – Universitätsmedizin Berlin and Shanghai Junshi Biosciences Co Ltd evaluating its lead product candidate, a multi-epitope, off-the-shelf tumor vaccine, in combination with an anti-PD1 and standard-of-care chemotherapy – an essential next step for advancing the care of these patients.”
M0re posts featuring Hagop Youssoufian.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 28, 2025, 15:15
Aug 28, 2025, 14:58
Aug 28, 2025, 14:33
Aug 28, 2025, 14:22
Aug 28, 2025, 14:13
Aug 28, 2025, 14:03
Aug 28, 2025, 13:48